Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BDSI

BioDelivery Sciences International (BDSI) Stock Price, News & Analysis

BioDelivery Sciences International logo

About BioDelivery Sciences International Stock (NASDAQ:BDSI)

Advanced Chart

Key Stats

Today's Range
$5.59
$5.60
50-Day Range
$5.54
$5.60
52-Week Range
$2.50
$5.62
Volume
2.09 million shs
Average Volume
3.34 million shs
Market Capitalization
$577.05 million
P/E Ratio
6.74
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BDSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioDelivery Sciences International and its competitors with MarketBeat's FREE daily newsletter.

BDSI Stock News Headlines

Florida International University
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Science
Jim Cramer's Top Stock Picks: DF MNST BDSI
See More Headlines

BDSI Stock Analysis - Frequently Asked Questions

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced its quarterly earnings results on Tuesday, November, 2nd. The specialty pharmaceutical company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.01. The specialty pharmaceutical company had revenue of $41.09 million for the quarter, compared to analyst estimates of $42.05 million. BioDelivery Sciences International had a net margin of 50.90% and a trailing twelve-month return on equity of 21.25%.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioDelivery Sciences International investors own include NVIDIA (NVDA), Bristol Myers Squibb (BMY), TG Therapeutics (TGTX), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
11/02/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:BDSI
CIK
1103021
Employees
200
Year Founded
1997

Profitability

EPS (Trailing Twelve Months)
$0.83
Trailing P/E Ratio
6.74
Forward P/E Ratio
14.71
P/E Growth
N/A
Net Income
$84.86 million
Net Margins
50.90%
Pretax Margin
17.77%
Return on Equity
21.25%
Return on Assets
10.56%

Debt

Debt-to-Equity Ratio
0.29
Current Ratio
2.45
Quick Ratio
2.17

Sales & Book Value

Annual Sales
$166.70 million
Price / Sales
3.46
Cash Flow
$0.36 per share
Price / Cash Flow
15.42
Book Value
$1.90 per share
Price / Book
2.94

Miscellaneous

Outstanding Shares
103,229,000
Free Float
92,927,000
Market Cap
$577.05 million
Optionable
Optionable
Beta
0.56

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:BDSI) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners